Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis.
Herrick
Ariane L
AL
Lunt
Mark
M
Silman
Alan J
AJ
Denton
Christopher P
CP
D002986:Clinical Trials as Topic; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012107:Research Design; D045743:Scleroderma, Diffuse / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid